FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Midazolam Injection, USP
Status: Currently in Shortage
»Date first posted: 04/02/2020
»Therapeutic Categories: Anesthesia; Neurology

Expand all

Akorn Pharmaceuticals (Revised 02/12/2021)

Company Contact Information:
800-932-5676

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
10 ML Vial - Pack of 10 (NDC 17478-0524-10) On backorder. Expected release - February 2021 Other

Gland Pharma Limited (Revised 03/30/2021)

Company Contact Information:
Athenex: 855-273-0154; Alvogen: 973-532-7840

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
50 mg per 10 mL Multi-Dose Vial (NDC 70860-601-10) No stock available. Resupply May 2021 Marketing partner: Athenex Pharmaceutical Division, LLC. Demand increase for the drug
25 mg per 5 mL Multi-Dose Vial (NDC 70860-601-05) No stock available. Resupply April 2021 Marketing partner: Athenex Pharmaceutical Division, LLC. Demand increase for the drug
25 mg per 5 mL Multi-Dose Vial (NDC 47781-589-17) No stock available Marketing partner: Alvogen Inc. Demand increase for the drug
50 mg per 10 mL Multi-Dose Vial (NDC 47781-589-91) Available. Additional supply April/May 2021 Marketing partner: Alvogen Inc. Demand increase for the drug
2 mg per 2 mL Single Dose Vial (NDC 70860-600-02) Available Marketing partner: Athenex Pharmaceutical Division, LLC. Demand increase for the drug
2 mg per 2 mL Single Dose Vial (NDC 47781-588-68) Available Marketing partner: Alvogen Inc. Demand increase for the drug

Heritage Pharmaceuticals d/b/a Avet Pharmaceuticals (Revised 03/05/2021)

Company Contact Information:
855-228-9470

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
50 mg/10mL vial (NDC 23155-601-42) On allocation due to increased demand Other
25 mg/5mL vial (NDC 23155-601-41) Available Other
2 mg/2mL vial (NDC 23155-600-41) Available Other

Hikma Pharmaceuticals USA, Inc. (formerly West-Ward) (Revised 04/08/2021)

Company Contact Information:
800-631-2174

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
1 mg/mL, 10 mL vial, 10 count (NDC 00641-6056-10) Available Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released. Demand increase for the drug
1 mg/mL, 2 mL vial, 25 count (NDC 00641-6057-25) Available Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released. Demand increase for the drug
1 mg/mL, 5 mL vial, 10 count (NDC 0641-6059-25) Available Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released. Demand increase for the drug
5 mg/mL, 1 mL vial, 25 count (NDC 00641-6061-25) Available Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released. Demand increase for the drug
5 mg/mL, 10 mL vial, 10 count (NDC 00641-6060-10) Available Additional lots are scheduled for manufacturing to meet demand. Product will be made available as it is released. Demand increase for the drug

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English